These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 16258103

  • 1. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.
    J Clin Oncol; 2005 Nov 01; 23(31):8048-56. PubMed ID: 16258103
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG, Mihm MC, Bufalino R, Zurrida S, Collini P, Cascinelli N.
    Cancer; 1996 Apr 01; 77(7):1303-10. PubMed ID: 8608507
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.
    J Clin Oncol; 2007 Mar 20; 25(9):1129-34. PubMed ID: 17369575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L.
    Br J Dermatol; 2007 Aug 20; 157(2):311-8. PubMed ID: 17596173
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C, Melzer K, Panageas KS, Li E, Kamino H, Kopf A, Cordon-Cardo C, Osman I, Polsky D.
    Cancer; 2002 Aug 01; 95(3):634-40. PubMed ID: 12209757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U, Buettner PG, Eigentler TK, Garbe C.
    J Clin Oncol; 2004 Sep 15; 22(18):3660-7. PubMed ID: 15302905
    [Abstract] [Full Text] [Related]

  • 13. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 14. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
    Lyle S, Salhany KE, Elder DE.
    Mod Pathol; 2000 Jan 05; 13(1):52-5. PubMed ID: 10658910
    [Abstract] [Full Text] [Related]

  • 15. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 16. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 17. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
    Litzner BR, Etufugh CN, Stepenaskie S, Hynan LS, Cockerell CJ.
    Am J Dermatopathol; 2012 Dec 01; 34(8):827-32. PubMed ID: 22878366
    [Abstract] [Full Text] [Related]

  • 18. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R.
    J Pathol; 2001 Dec 01; 195(5):530-6. PubMed ID: 11745687
    [Abstract] [Full Text] [Related]

  • 19. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 01; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 20. A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53.
    Väisänen A, Kuvaja P, Kallioinen M, Turpeenniemi-Hujanen T.
    Hum Pathol; 2011 Aug 01; 42(8):1103-11. PubMed ID: 21334717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.